Epidermodysplasia verruciformis (EV) is a rare human genetic predisposition to develop flat warts, some of which subsequently undergo cancer transformation. Some human papillomaviruses (HPVs), i.e. HPV 5 and 8, have been associated with cancer development as a sequela of EV. As similar diseases have been observed in dogs, it was hypothesized that unknown canine papillomaviruses (CPVs) may exist and that they may be present in cases of canine EV. Consequently, DNA was extracted from a malignant lesion of a dog with EV and circular DNA was amplified by multiple-primed rolling-circle amplification (RCA). Indeed, sequence determination and analysis of the RCA-amplified and cloned DNA from a malignant canine EV lesion resulted in the detection and primary description of a third CPV (CPV3). Typical papillomavirus genes were identified, with deduced amino acid similarities ranging from 20 to 57 % for E1, E2, E6, E7, L1 and L2, respectively. According to the sequence of the L1 gene, which is used for papillomavirus classification, the new isolate meets the majority of criteria needed to declare detection of a novel genus among the papillomaviruses. Thus, CPV3 may represent the prototype of this novel genus. As the novel virus was found in a dog in association with lesions reminiscent of human EV, it should be interesting to test in the future whether this condition can be reproduced in experimental animals. If such were the case, a new model for EV could be established.
INTRODUCTION
Epidermodysplasia verruciformis (EV) is a rare human genetic predisposition to develop flat warts, some of which subsequently undergo cancer transformation (de Oliveira et al., 2003) . Numerous viruses have been uncovered in EV lesions, but some, such as human papillomaviruses (HPV) 5 and 8, have been associated with cancer development (Nuovo & Ishag, 2000) . Similarly, cases in dogs of pigmented plaques (PP) that develop subsequently into squamous-cell carcinoma (SCC) are well documented (Briggs, 1985; Gross & Brimacomb, 1986; Nagata et al., 1995; Stokking et al., 2004; Walder, 1997) . Indeed, Nagata et al. (1995) have described conditions similar to EV in dogs, terming these conditions the canine counterpart to human EV. Whilst the classical canine oral papillomavirus (COPV) is able to induce typical warts, neither genomic sequences of COPV nor typical histological lesions thereof have yet been described in association with canine EV (Nagata et al., 1995; Scott et al., 2001) . However, Tanabe et al. (2000) amplified a small sequence identified as a part of the papillomavirus L1 gene from such lesions and showed that it differed from its COPV counterpart. Based on preliminary data, including PCR amplification and sequencing of the amplification products (Zaugg et al., 2005) , we hypothesized that unknown canine papillomaviruses (CPVs) may exist and that they may be detected in cases of canine EV. Consequently, we extracted DNA from lesions of a dog with suspected EV and amplified circular DNA by the recently described multiple-primed rolling-circle amplification (RCA) method, which has been shown to be useful for the cloning of entire papillomavirus genomes (Dean et al., 2001; Rector et al., 2004a Rector et al., , b, 2005 . Indeed, papillomaviruslike DNA was amplified from canine EV before being cloned and sequenced. Sequence determination and analysis resulted in the detection and primary description of a third CPV (CPV3). Moreover, the new isolate meets the majority of criteria needed to declare detection of a novel genus among the papillomaviruses (de Villiers et al., 2004) .
METHODS
Clinical history. A 6-year-old Rhodesian ridgeback dog was examined for the presence of multiple non-pruritic hyperpigmented cutaneous hyperplasia. The first macular lesions were noticed by the The GenBank/EMBL/DDBJ accession number for the nucleotide sequence data of CPV3 is DQ295066.
owner when the dog was 6 months old. Lesions subsequently increased in number and size. Based on the clinical aspect, a diagnosis of pigmented nevi was made and the dog remained untreated. One of these lesions suddenly developed into malignancy and ulceration.
Tissue samples. Full-thickness biopsies of each type of lesion and adjacent normal skin were taken. One set of biopsies was fixed in 10 % neutral-buffered formalin, embedded in paraffin, sectioned to 4-6 mm slices, mounted onto glass slides and stained with haematoxylin and eosin (H&E) for light microscopy. A second set of tissue was kept at 220 uC until DNA extraction.
Amplification and cloning of genome. Total DNA from 25 mg tissue (various lesions) was isolated by using a DNeasy extraction kit (Qiagen) according to the manufacturer's recommendations. DNA (1 ml) was used for RCA (Rector et al., 2004b) , using a TempliPhi Amplification kit (Amersham Biosciences). The polymerase reaction was primed with protected, random hexamers as supplied in the kit. The protocol supplied by the manufacturer was used, except for a prolonged reaction time for 16 h at 30 uC. Amplified DNA was cloned into the SacI site of pBluescript II-KS + (Stratagene) by using standard procedures.
Sequence analysis. The nucleotide sequence of cloned DNA was determined commercially (Microsynth) by cycle sequencing using an ABI 377 sequencer (Applied Biosystems). The primary sequence was then analysed by using the software packages Vector NTI (Informax) and GCG version 10.3 (Accelrys). Program parameters were set to default except where indicated otherwise. Phylogenetic analyses were performed with CLUSTAL_X version 1.83 (Jeanmougin et al., 1998) and PHYLIP version 3.63 (Felsenstein, 2004) . A multiple sequence alignment using CLUSTAL_X was calculated with the default parameters (UIB DNA matrix). A bootstrapped (1000 datasets) phylogenetic tree was constructed with PHYLIP, using sequentially the programs SEQBOOT, DNADIST, NEIGHBOR and DRAWTREE. The quality of the tree was evaluated with CONSENSE. The nucleotide sequence data of CPV3 were deposited in GenBank under accession no. DQ295066. GenBank accession numbers of sequences used for multiple sequence alignment are shown in Table 1 .
RESULTS

Case determination
A 6-year-old Rhodesian ridgeback dog presented with more than 100 hyperpigmented lesions, including squamous maculae (4 mm to 1?5 cm in diameter), papillomatous papules (small, in groups), small to pedunculated warts (a few millimetres to 1 cm) and one large, ulcerated, interdigital plaque. Clinical differential diagnosis included cutaneous nevi, canine EV-like disease, basal-cell carcinoma, SCC and melanocytic neoplasia. Several skin biopsies were taken for histological examination. Fig. 1 exemplifies the histology found in the two main types of lesion. Histology revealed variable acanthosis, ranging from moderate in maculae to pronounced in the ulcerated lesion. Furthermore, microscopic observations included ortho-and sometimes parakeratotic hyperkeratosis, marked hyperpigmentation of all layers of the epidermis, scattered dyskeratotic cells and a marked hypergranulosis with clumped keratohyalin granules. Based on these findings, the diagnosis of canine EV was made. Loss of polarity and nests of basaloid cells were noticed in some sections. The HPV1  NC_001581  HPV3  NC_001588  HPV4  NC_001457  HPV5  NC_001531  HPV6  X00203  HPV7  X74463  HPV9  NC_001596  HPV12  NC_001577  HPV13  NC_001349  HPV15  NC_001579  HPV16  K02718  HPV18  X05015  HPV19  NC_001581  HPV22  NC_001681  HPV23  NC_001682  HPV29  NC_001685  HPV30  X74474  HPV32  X74475  HPV35  X74477  HPV37  NC_001687  HPV41  NC_001354  HPV44  NC_001689  HPV49  NC_001591  HPV50  NC_001691  HPV51  NC_001533  HPV52  NC_001592  HPV53  NC_001593  HPV54  U37488  HPV56  NC_001594  HPV60  NC_001693  HPV63  NC_001458  HPV65  NC_001459  HPV75  Y15173  HPV76  Y15174  HPV95 changes were most pronounced in the samples from the ulcerated lesions, where numerous atypia, such as macrocaryosis, anisocaryosis, multinucleated cells or abnormal mitosis, were also present. However, the basal membrane always remained intact. Furthermore, the ulcerated lesion was diagnosed as an in situ SCC. Based on results from a broad-range PCR, suitable for the detection of a wide variety of papillomaviruses, it was hypothesized that this case may be associated with a novel CPV infection (Zaugg et al., 2005) .
Amplification and sequencing reveal papillomavirus-like DNA DNA extracted from skin biopsies was amplified by RCA as described in Methods. Amplified, concatemeric DNA was digested with a set of restriction enzymes, including EcoRI and SalI, to find a potential single-recognition site that would allow cloning the papillomavirus genome in its entirety. However, initially such a site was not found (data not shown). Therefore, the subgenomic EcoRI and SalI fragments were cloned. Digestion of RCA-amplified DNA with EcoRI resulted in four (3664, 3025, 1000 and 112 bp) and digestion with SalI resulted in three (3868, 2067 and 1866 bp) fragments. Initial sequence information of the resulting cloned fragments was taken to evaluate further potential single-cutting restriction enzymes, among which SacI seemed to cut the amplified genome only once. Therefore, the RCA-amplified DNA was cloned after SacI digestion into pBluescript and restriction-enzyme analysis of the cloned DNA was performed, using BamHI, HindIII, EcoRI, SalI and SacI. The resulting restriction-enzyme patterns confirmed and extended the previous findings (Fig. 2) .
Determination of the entire cloned sequence revealed that papillomavirus sequences had actually been detected, which consisted of 7801 bp. Open reading frame (ORF) analysis revealed the presence of four long and two short ORFs. These ORFs potentially encode the E1, E2, L2, L1, E6 and E7 proteins, respectively (Fig. 3) . Furthermore, the long control region (LCR), between the end of the L1 gene and the start of the E6 gene, was 566 bp in length. The SacI site used for cloning was located at the end of the ORF encoding the E2 protein. Deduced amino acid sequences of the putative proteins revealed an ATP-dependent helicase motif (GPPDTGKS) (Wilson et al., 2002) in the C-terminal region of E1, two putative metal-binding motifs (CX 2 CX 29 CX 2 C) in the deduced amino acid sequences of E6 and one such motif in E7 (Münger et al., 2004) . The amino acid sequences of both structural proteins L1 and L2 were predicted to harbour a basic tail at their C termini. The locations of the predicted ORFs are described in Table 2 (a).
In addition, well-known papillomavirus-specific DNA motifs were identified in the novel genome sequence. Ten consensus sequences for E2 binding (ACCN 6 GGT) (Androphy et al., 1987) were detected; seven of them were located in the LCR (positions 7372-7385, 7435-7448, 7541-7554, 7581-7594, 7672-7685, 7731-7744 and 7754-7767) (Nagata et al., 1995; Nuovo & Ishag, 2000) . Here, they are characterized by scalloped configuration of the epidermis, irregular acanthosis, hyperpigmentation and a prominent granular layer with clumped keratohyalin granules (white arrow). Keratinocyte maturation is normal. However, some scattered cytopathic keratinocytes with vacuolated cytoplasm (black arrows) are observed. Bar, 50 mm. (b) Canine in situ SCC is marked by irregular acanthosis with rete ridge formation and disorganization of the epidermis. However, the basal membrane remains intact (black arrow). Bar, 200 mm. At higher magnification (insert), anisocaryosis (white arrows) and binucleated keratinocytes (black arrow) are seen. Bar, 50 mm.
of them is probably the signal for processing the early protein pre-mRNA and the second the signal for the late pre-mRNA. Thus, all important elements present in a papillomavirus genome were detected. Therefore, the CPV with the presently determined sequence was termed CPV type 3 (CPV3).
Comparison of CPV3 with known PV genomes
In order to address the possible classification of CPV3, alignments were made at the nucleotide sequence level of single ORFs and the translated individual ORFs were compared at either the nucleotide or the amino acid sequence level. First, a phylogenetic tree was constructed based on the multiple sequence alignment of L1 nucleotide sequences (Fig. 4) . CPV3 did not group into any of the defined papillomavirus genera, but occupied a position on a side branch to the d-and e-papillomaviruses. Apparently, bovine BPV5 (an e-papillomavirus) and bovine BPV1 and 2, ovine OvPV1 and 2, European elk EEPV and deer DPV (dpapillomaviruses) represent, thus far, the closest relatives.
Next, the putative amino acid sequences of predicted CPV3 proteins were aligned to their homologues in these most closely related viruses (Table 2a) . Under these conditions, CPV3's E1 protein sequence was more similar to the homologues of COPV and CPV2 (43 %) than to those of OvPV1 and 2, EEPV and DPV, and BPV1, 2 and 5 (37-42 %). Likewise, the L2, E7 and E6 proteins of CPV3 were more similar to those of COPV and CPV2. However, the L1 protein sequence of CPV3 was less similar to the corresponding protein sequence of CPV2 and COPV (47 and 52 %, respectively) than to BPV1, 2 and 5, OvPV1 and 2, and EEPV (49-55 %). Although only partial sequences of a predicted additional CPV, CPV-PEN, are publicly available (Tanabe et al., 2000) , the L1 protein gene of CPV-PEN was compared at the nucleotide and amino acid levels with the corresponding sequences of COPV, CPV2 and CPV3. According to this analysis, CPV3 shared about 70 % sequence identity with CPV-PEN, at both the nucleotide and the amino acid levels, but only about 50 % with the other CPVs (data not shown). Yet, the comparison suggested that CPV3 and CPV-PEN are probably still two distinct viruses.
According to the rules of the International Committee on Taxonomy of Viruses (ICTV), the criteria for the definition of a separate PV genus are fulfilled if <60 % nucleotide sequence identity in the L1 ORF is shared and if complete genomes have >23 %, but <43 % nucleotide sequence identity (de Villiers et al., 2004) . To address this issue properly, pairwise sequence alignments covering the L1 ORF and the entire genomic sequences were performed at the nucleotide level. Calculated identities between CPV3 and the corresponding sequences of the most closely related papillomaviruses are listed in Table 2 (b). The closest relative to CPV3 was BPV2, with 59 % nucleotide sequence identity in the L1 ORF. Similarly, 58 % identity was found with BPV5 and OvPV2, respectively, whereas the canine PVs retained 56 % (COPV) and 55 % (CPV2) identity in L1. Interestingly, the identities on the entire genome sequences were lower for BPV2 (47 %) and BPV5 (46 %) than for OvPV2 (48 %) and the highest identities to the CPV3 genome sequence were Fig. 2 . Restriction-enzyme digest of cloned CPV3 genome. Plasmid DNA (1 mg) was digested with restriction enzymes as indicated above the lanes and digested DNA was run through 1 % agarose in TAE. As molecular mass marker, a 1 kb ladder (Invitrogen) was run in parallel. calculated to COPV and CPV2 (50 and 49 %, respectively). Thus, the criteria to declare detection of the prototype of a novel PV genus are met at least partially.
DISCUSSION
Although not being identical, human EV and canine PP share numerous features. Both conditions are characterized by the onset of flat warts and the subsequent progressive development of SCC in about one-third of affected individuals (de Oliveira et al., 2003; Nagata et al., 1995) . In both cases, families or breeds appear to be predisposed to these conditions, even though similar changes may be observed in non-predisposed, immunosuppressed individuals (de Oliveira et al., 2003; Morrison et al., 2002; Nagata et al., 1995; Stokking et al., 2004) . Histologically, both conditions exhibit specific changes that are clearly different from the features of classical warts (Nagata et al., 1995;  (Jeanmougin et al., 1998) and the tree was constructed with PHYLIP (Felsenstein, 2004) . GenBank accession numbers are given in Table 1 . Nuovo & Ishag, 2000) . Of note, both conditions seem to be induced by specific papillomaviruses. In humans, EVassociated HPVs, such as HPV 5 and 8, are regularly, but not exclusively, found in EV lesions and are sometimes found in normal skin or skin associated with non-PVinduced conditions (Antonsson et al., 2000; Li et al., 2004) . Tanabe et al. (2000) reported the sequencing of a small portion of the genome of one virus (CPV-PEN) found in PP lesions in dogs. The clinical signs described in that report were similar to our observations.
Throughout the present work, we amplified a circular DNA with identical restriction-enzyme patterns (data not shown) from several benign lesions, as well as one malignant lesion, of a dog with an EV-like syndrome. The malignant lesion was diagnosed as canine in situ SCC. Following cloning of this DNA, nucleotide sequence determination indicated that it corresponded to a novel papillomavirus, which was termed CPV3.
Further sequence analysis of CPV3 revealed typical elements common to papillomaviruses. In particular, we were able to assign the ORFs potentially encoding L1, L2, E1, E2, E6 and E7. In addition, several recognition sites for E2 DNA binding and two polyadenylation signals were detected. Multiple sequence alignment of the nucleotide sequence encoding L1 allowed the construction of a phylogenetic tree. The criteria of ICTV to be met for declaration of a separate papillomavirus genus were met almost perfectly. Therefore, the novel papillomavirus described in this communication may represent the first member of a novel papillomavirus genus. It occupies a position on the phylogenetic tree in the neighbourhood of the e-papillomaviruses (BPV1, 2 and 5) and the d-papillomaviruses (OvPV1 and 2, European elk EEPV and deer DPV). The other CPVs included in the phylogenetic analysis were clearly on distinct branches of the tree.
CPV-PEN, a predicted, but hitherto incompletely sequenced, CPV, which has been associated with a clinical disease similar to that associated with CPV3, showed the closest relatedness to CPV3 within the L1 gene sequence (70 % identity). This hypothesis suggests that viruses similar to CPV3 circulate in the canine population and are found in association with EV. Therefore, this new group of papillomaviruses may be of considerable veterinary and, probably, medical interest.
Based on our observations, it would be interesting to compare the entire genome sequence of CPV-PEN with the CPV3 sequence reported here. In particular, the sequences of E6 (and E7) might reveal a connection of the clinical signs and the genome sequences.
In conclusion, we detected and determined the genomic sequence of a novel papillomavirus, which may represent a novel genus within this virus family. The novel virus was found in a dog in association with lesions reminiscent of human EV. Moreover, CPV3 E6 mRNA expression was detected in three different lesions of this dog, but not in its healthy skin (data not shown). Furthermore, sequencing of p53 cDNA obtained from lesions and from normal skin revealed no mutation in comparison with the published canine p53 sequence (GenBank accession no. AB020761). These two additional observations sustain the idea of a possible causative association between this novel virus and the disease.
It should be interesting to test in the future whether this condition can be reproduced in experimental animals. If such were the case, a new model for EV could be established on the basis of a natural host species.
